Latest Attention-deficit hyperactivity disorder management Stories
MONMOUTH JUNCTION, N.J., July 28 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced that the US Food and Drug Administration (FDA) has approved a first-time generic of Methylphenidate Hydrochloride Oral Solution equivalent to brand name MethylinÂ® Oral Solution marketed by Shionogi Pharmaceuticals, Inc. "Tris pursues selective generic opportunities, especially the difficult to formulate or complex formulations and...
DUBLIN and PHILADELPHIA, July 6 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced the US Food and Drug Administration (FDA) approval of DaytranaÂ® (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents aged 13 to 17 years.
MILLER PLACE, N.Y., June 25 /PRNewswire/ -- The Child and Adult Diagnostic and Treatment Program for ADHD, a division of East End Psychological Services, provides testing and state-of-the-art treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) across the lifespan.
BRENTWOOD, Tenn., June 23 /PRNewswire/ -- Learning Lab, Brentwood will present a free seminar, Does My Child Have ADHD? Diagnosing and What's Next?, on Thursday June 24, 2010 from 7:00-8:00 PM at the Maryland Farms YMCA in Brentwood. The seminar will be presented by Dr.
A new study published online in the Journal of Pediatrics suggests that neither attention deficit hyperactivity disorder (ADHD) nor medications used to treat it have a long-term impact on kids' growth.
NEW ORLEANS, May 25 /PRNewswire/ -- Turning in assignments, following instructions and focusing on learning something new are among the daily classroom challenges for children with Attention Deficit Hyperactivity Disorder (ADHD),(1) according to the National Institute of Mental Health (NIMH).
ORLANDO, Fla., May 19 /PRNewswire-FirstCall/ -- In growing numbers, children across America are adding a dose of medicine to their daily routine.
CHICAGO, May 11 /PRNewswire/ -- Adderall is a drug widely reported to increase alertness, concentration and overall cognitive performance, while decreasing fatigue - but it is also a drug widely abused across college campuses.
Children with ADHD who carry a specific type of dopamine receptor gene respond better to the drug methylphenidate (MPH) than those without the genotype, according to new research from Cincinnati Children's Hospital Medical Center.
PHILADELPHIA, May 4 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved a change to the prescribing information for its once-daily Attention Deficit Hyperactivity Disorder (ADHD) treatment VyvanseÂ® (lisdexamfetamine dimesylate) Capsules CII, to include supplemental data demonstrating significant improvement in attention in adults with ADHD across all six...